Palisade Bio Inc. (NASDAQ:PALI) went down by -13.67% from its latest closing price compared to the recent 1-year high of $16.02. The company’s stock price has collected -34.82% of loss in the last five trading sessions. Press Release reported on 04/26/21 that Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.
Is It Worth Investing in Palisade Bio Inc. (NASDAQ :PALI) Right Now?
Plus, the 36-month beta value for PALI is at 1.74. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Palisade Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3120.00. PALI currently public float of 2.86M and currently shorts hold a 10.00% ratio of that float. Today, the average trading volume of PALI was 583.02K shares.
PALI’s Market Performance
PALI stocks went down by -34.82% for the week, with a monthly drop of -35.21% and a quarterly performance of -22.61%, while its annual performance rate touched 58.70%. The volatility ratio for the week stands at 21.02% while the volatility levels for the past 30 days are set at 13.55% for Palisade Bio Inc.. The simple moving average for the period of the last 20 days is -30.51% for PALI stocks with a simple moving average of 6.71% for the last 200 days.
PALI Trading at -29.30% from the 50-Day Moving Average
After a stumble in the market that brought PALI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.99% of loss for the given period.
Volatility was left at 13.55%, however, over the last 30 days, the volatility rate increased by 21.02%, as shares sank -39.17% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.49% lower at present.
During the last 5 trading sessions, PALI fell by -34.82%, which changed the moving average for the period of 200-days by +44.33% in comparison to the 20-day moving average, which settled at $9.24. In addition, Palisade Bio Inc. saw 24.43% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for PALI
Current profitability levels for the company are sitting at:
- -78961.14 for the present operating margin
The net margin for Palisade Bio Inc. stands at -120316.72. The total capital return value is set at -141.63, while invested capital returns managed to touch -216.28. Equity return is now at value -129.90, with -114.80 for asset returns.
The receivables turnover for the company is 0.20 and the total asset turnover is 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.02.